Hexavalent chromium-induced apoptosis of granulosa cells involves selective sub-cellular translocation of Bcl-2 members, ERK1/2 and p53

Toxicology and Applied Pharmacology

Volumn 251, Issue 3, 2011, Pages 253-266

  Banu, Sakhila K ^a   Stanley, Jone A ^a   Lee, JeHoon ^a   Stephen, Sam D ^a   Arosh, Joe A ^a   Hoyer, Patricia B ^b   Burghardt, Robert C ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Bcl 2; Chromium; Ovary; P53

Indexed keywords

ASCORBIC ACID; CASPASE 3; DICHROMATE POTASSIUM; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; SERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GRANULOSA CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; TRANSCRIPTION INITIATION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; ASCORBIC ACID; CHROMIUM; DNA FRAGMENTATION; DOWN-REGULATION; FEMALE; GRANULOSA CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

RATTUS;

EID: 79952006055     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.01.011     Document Type: Article

References (91)

1. Agarwal M.L., Agarwal A., Taylor W.R., Chernova O., Sharma Y., Stark G.R. A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc. Natl Acad. Sci. USA 1998, 95:14775-14780.
2. Banu S.K., Lee J., Starzinski-Powitz A., Arosh J.A. Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells. Fertil. Steril. 2008, 90:972-987.
3. Banu S.K., Lee J., Satterfield M.C., Spencer T.E., Bazer F.W., Arosh J.A. Molecular cloning and characterization of prostaglandin transporter in ovine endometrium: role of mitogen activated protein kinase pathways in release of prostaglandin F2 alpha. Endocrinology 2008, 149:219-231.
4. Banu S.K., Samuel J.B., Arosh J.A., Burghardt R.C., Aruldhas M.M. Lactational exposure to hexavalent chromium delays puberty by impairing ovarian development, steroidogenesis and pituitary hormone synthesis in developing Wistar rats. Toxicol. Appl. Pharmacol. 2008, 232:180-189.
5. Banu S.K., Lee J., Speights V.O., Starzinski-Powitz A., Arosh J.A. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms. Mol. Endocrinol. 2009, 23:1291-1305.
6. Barceloux D.G. Chromium. J. Toxicol. Clin. Toxicol. 1999, 37:173-194.
7. Bivik C., Rosdahl I., Ollinger K. Hsp70 protects against UVB induced apoptosis by preventing release of cathepsins and cytochrome c in human melanocytes. Carcinogenesis 2007, 28:537-544.
8. BlacksmithInstitute Top 10 Worst Polluted Sites 2007, The Blacksmith Institute, New York.
9. Blankenship L.J., Carlisle D.L., Wise J.P., Orenstein J.M., Dye L.E., Patierno S.R. Induction of apoptotic cell death by particulate lead chromate: differential effects of vitamins C and E on genotoxicity and survival. Toxicol. Appl. Pharmacol. 1997, 146:270-280.
10. Brantley-Finley C., Lyle C.S., Du L., Goodwin M.E., Hall T., Szwedo D., Kaushal G.P., Chambers T.C. The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem. Pharmacol. 2003, 66:459-469.
11. Brooks C.L., Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr. Opin. Cell Biol. 2003, 15:164-171.
12. Cox M.L., Meek D.W. Phosphorylation of serine 392 in p53 is a common and integral event during p53 induction by diverse stimuli. Cell. Signal. 2010, 22:564-571.
13. Dagda R.K., Zhu J., Kulich S.M., Chu C.T. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy 2008, 4:770-782.
14. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
15. Dayan A.D., Paine A.J. Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000. Hum. Exp. Toxicol. 2001, 20:439-451.
16. Dumaz N., Meek D.W. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 1999, 18:7002-7010.
17. Erster S., Moll U.M. Stress-induced p53 runs a direct mitochondrial death program: its role in physiologic and pathophysiologic stress responses in vivo. Cell Cycle 2004, 3:1492-1495.
18. Fan H.Y., Liu Z., Shimada M., Sterneck E., Johnson P.F., Hedrick S.M., Richards J.S. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science 2009, 324:938-941.
19. Galluzzi L., Morselli E., Kepp O., Vitale I., Pinti M., Kroemer G. Mitochondrial liaisons of p53. Antioxid. Redox Signal 2010, Jan 7, [Epub ahead of print].
20. Giaccia A.J., Kastan M.B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 1998, 12:2973-2983.
21. Gladys S., Van Meerbeek B., Lambrechts P., Vanherle G. Evaluation of esthetic parameters of resin-modified glass-ionomer materials and a polyacid-modified resin composite in Class V cervical lesions. Quintessence Int. 1999, 30:607-614.
22. Hetman M., Kanning K., Cavanaugh J.E., Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 1999, 274:22569-22580.
23. Hirshfield A.N. Overview of ovarian follicular development: considerations for the toxicologist. Environ. Mol. Mutagen. 1997, 29:10-15.
24. Holley A.K., Dhar S.K., St Clair D.K. Manganese superoxide dismutase versus p53: the mitochondrial center. Ann. NY Acad. Sci. 2010, 1201:72-78.
25. Holley A.K., Dhar S.K., St Clair D.K. Manganese superoxide dismutase vs. p53: regulation of mitochondrial ROS. Mitochondrion 2010, 10:649-661.
26. Holley A.K., Dhar S.K., Xu Y., St Clair D.K. Manganese superoxide dismutase: beyond life and death. Amino Acids 2010, May 8, [Epub ahead of print].
27. Hoyer P. Impact of Metals on Ovarian Function. Metals, Fertility, and Reproductive Toxicity 2005, 155-169. Taylor & Francis. M.S. Golub (Ed.).
28. Jacquet P., Draye J.P. Toxicity of chromium salts to cultured mouse embryos. Toxicol. Lett. 1982, 12:53-57.
29. Jardine L.J., Milne D.M., Dumaz N., Meek D.W. Phosphorylation of murine p53, but not human p53, by MAP kinase in vitro and in cultured cells highlights species-dependent variation in post-translational modification. Oncogene 1999, 18:7602-7607.
30. Jiang X., Wang X. Cytochrome c-mediated apoptosis. Annu. Rev. Biochem. 2004, 73:87-106.
31. Joly A.L., Wettstein G., Mignot G., Ghiringhelli F., Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun 2010, 2:238-247.
32. Junaid M., Murthy R.C., Saxena D.K. Embryo- and fetotoxicity of chromium in pregestationally exposed mice. Bull. Environ. Contam. Toxicol. 1996, 57:327-334.
33. Kamath S.M., Stoecker B.J., Davis-Whitenack M.L., Smith M.M., Adeleye B.O., Sangiah S. Absorption, retention and urinary excretion of chromium-51 in rats pretreated with indomethacin and dosed with dimethylprostaglandin E2, misoprostol or prostacyclin. J. Nutr. 1997, 127:478-482.
34. Kang B.H., Plescia J., Dohi T., Rosa J., Doxsey S.J., Altieri D.C. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 2007, 131:257-270.
35. Kanojia R.K., Junaid M., Murthy R.C. Embryo and fetotoxicity of hexavalent chromium: a long-term study. Toxicol. Lett. 1998, 95:165-172.
36. Kayampilly P.P., Menon K.M. Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells. Endocrinology 2007, 148:3950-3957.
37. Kirpnick-Sobol Z., Reliene R., Schiestl R.H. Carcinogenic Cr(VI) and the nutritional supplement Cr(III) induce DNA deletions in yeast and mice. Cancer Res. 2006, 66:3480-3484.
38. Kulich S.M., Chu C.T. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease. J. Neurochem. 2001, 77:1058-1066.
39. Kulich S.M., Chu C.T. Role of reactive oxygen species in extracellular signal-regulated protein kinase phosphorylation and 6-hydroxydopamine cytotoxicity. J. Biosci. 2003, 28:83-89.
40. Kurihara A., Nagoshi H., Yabuki M., Okuyama R., Obinata M., Ikawa S. Ser46 phosphorylation of p53 is not always sufficient to induce apoptosis: multiple mechanisms of regulation of p53-dependent apoptosis. Genes Cells 2007, 12:853-861.
41. Lanneau D., de Thonel A., Maurel S., Didelot C., Garrido C. Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion 2007, 1:53-60.
42. Lidke D.S., Huang F., Post J.N., Rieger B., Wilsbacher J., Thomas J.L., Pouyssegur J., Jovin T.M., Lenormand P. ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation. J. Biol. Chem. 2010, 285:3092-3102.
43. Long X., Goldenthal M.J., Marin-Garcia J. Oxidative stress enhances phosphorylation of p53 in neonatal rat cardiomyocytes. Mol. Cell. Biochem. 2007, 303:167-174.
44. Makarov Y., Shimtova L.A. Occupational conditions and gynecological illness in workers engaged in the production of chromium compounds. Environ. Health Perspect. 1978, 24:1-128.
45. Matsuda-Minehata F., Inoue N., Goto Y., Manabe N. The regulation of ovarian granulosa cell death by pro- and anti-apoptotic molecules. J. Reprod. Dev. 2006, 52:695-705.
46. Matsuzawa A., Nishitoh H., Tobiume K., Takeda K., Ichijo H. Physiological roles of ASK1-mediated signal transduction in oxidative stress- and endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice. Antioxid. Redox Signal. 2002, 4:415-425.
47. Meek D.W. Multisite phosphorylation and the integration of stress signals at p53. Cell. Signal. 1998, 10:159-166.
48. Meek D.W. New developments in the multi-site phosphorylation and integration of stress signalling at p53. Int. J. Radiat. Biol. 1998, 74:729-737.
49. Meek D.W. Tumour suppression by p53: a role for the DNA damage response?. Nat. Rev. Cancer 2009, 9:714-723.
50. Meek D.W., Anderson C.W. Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol 2009, 1:a000950.
51. Meek D.W., Campbell L.E., Jardine L.J., Knippschild U., McKendrick L., Milne D.M. Multi-site phosphorylation of p53 by protein kinases inducible by p53 and DNA damage. Biochem. Soc. Trans. 1997, 25:416-419.
52. Meloche S., Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007, 26:3227-3239.
53. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
54. Milczarek G.J., Martinez J., Bowden G.T. p53 Phosphorylation: biochemical and functional consequences. Life Sci. 1997, 60:1-11.
55. Milne D.M., Campbell L.E., Campbell D.G., Meek D.W. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1. J. Biol. Chem. 1995, 270:5511-5518.
56. Moll U.M., Petrenko O. The MDM2-p53 interaction. Mol. Cancer Res. 2003, 1:1001-1008.
57. Murthy R.C., Junaid M., Saxena D.K. Ovarian dysfunction in mice following chromium (VI) exposure. Toxicol. Lett. 1996, 89:147-154.
58. Neckers L., Kern A., Tsutsumi S. Hsp90 inhibitors disrupt mitochondrial homeostasis in cancer cells. Chem. Biol. 2007, 14:1204-1206.
59. Nishikimi M., Fukuyama R., Minoshima S., Shimizu N., Yagi K. Cloning and chromosomal mapping of the human nonfunctional gene for l-gulono-gamma-lactone oxidase, the enzyme for l-ascorbic acid biosynthesis missing in man. J. Biol. Chem. 1994, 269:13685-13688.
60. Nriagu J. Chromium in the Natural and Human Environments 1988, Wiley Inter-Science.
61. O'Brien T.J., Ceryak S., Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res. 2003, 533:3-36.
62. Pani G., Colavitti R., Bedogni B., Fusco S., Ferraro D., Borrello S., Galeotti T. Mitochondrial superoxide dismutase: a promising target for new anticancer therapies. Curr. Med. Chem. 2004, 11:1299-1308.
63. Poderoso C., Converso D.P., Maloberti P., Duarte A., Neuman I., Galli S., Maciel F.C., Paz C., Carreras M.C., Poderoso J.J., Podesta E.J. A mitochondrial kinase complex is essential to mediate an ERK1/2-dependent phosphorylation of a key regulatory protein in steroid biosynthesis. PLoS ONE 2008, 3:e1443.
64. Rana S.V. Metals and apoptosis: recent developments. J. Trace Elem. Med. Biol. 2008, 22:262-284.
65. Rapp U.R., Fischer A., Rennefahrt U.E., Hekman M., Albert S. BAD association with membranes is regulated by Raf kinases and association with 14-3-3 proteins. Adv. Enzyme Regul. 2007, 47:281-285.
66. Salnikow K., Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 2008, 21:28-44.
67. Samuel J.B., Stanley J.A., Roopha D.P., Vengatesh G., Anbalagan J., Banu S.K., Aruldhas M.M. Lactational hexavalent chromium exposure-induced oxidative stress in rat uterus is associated with delayed puberty and impaired gonadotropin levels. Hum. Exp. Toxicol 2010, Mar 4, [Epub ahead of print].
68. Schuler M., Green D.R. Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 2001, 29:684-688.
69. Shi H., Hudson L.G., Liu K.J. Oxidative stress and apoptosis in metal ion-induced carcinogenesis. Free Radic. Biol. Med. 2004, 37:582-593.
70. Shieh S.Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334.
71. Shmitova L. The course of pregnancy in women engaged in the production of chromium and its compounds. Sverdlovsk 1978, 19:108-111.
72. Shmitova L. Content of hexavalent chromium in the biological substrates of pregnant woen and women in the immediate postnatal period engaged in the manufacture of chromium compounds. Gig Trud Prof Zabol 1980, 2:32-35.
73. Siu P.M., Wang Y., Alway S.E. Apoptotic signaling induced by H2O2-mediated oxidative stress in differentiated C2C12 myotubes. Life Sci. 2009, 84:468-481.
74. Sluss H.K., Gannon H., Coles A.H., Shen Q., Eischen C.M., Jones S.N. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis. Mol. Cancer Res. 2010, 8:216-222.
75. Stadheim T.A., Xiao H., Eastman A. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells. Cancer Res. 2001, 61:1533-1540.
76. Stanciu M., DeFranco D.B. Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J. Biol. Chem. 2002, 277:4010-4017.
77. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M.R., Johnson J.W., DeFranco D.B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 2000, 275:12200-12206.
78. Stankiewicz A.R., Lachapelle G., Foo C.P., Radicioni S.M., Mosser D.D. Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J. Biol. Chem. 2005, 280:38729-38739.
79. Sutton R. Chromium-6 in U.S. Tap Water 2010, 1-23. Environmental Working Group, Washington, DC. R.S. Jane Houlihan, N. Bruzelius (Eds.).
80. Tipton I.H., Shafer J.J. Statistical Analysis of Lung Trace Element Levels. Arch. Environ. Health 1964, 8:58-67.
81. Tsuruta F., Sunayama J., Mori Y., Hattori S., Shimizu S., Tsujimoto Y., Yoshioka K., Masuyama N., Gotoh Y. JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J. 2004, 23:1889-1899.
82. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12:1161-1208.
83. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40.
84. Verschoor M.L., Wilson L.A., Singh G. Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can. J. Physiol. Pharmacol. 2010, 88:204-219.
85. Ye J., Wang S., Leonard S.S., Sun Y., Butterworth L., Antonini J., Ding M., Rojanasakul Y., Vallyathan V., Castranova V., Shi X. Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J. Biol. Chem. 1999, 274:34974-34980.
86. Yeh P.Y., Chuang S.E., Yeh K.H., Song Y.C., Chang L.L., Cheng A.L. Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death. Oncogene 2004, 23:3580-3588.
87. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
88. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996, 87:619-628.
89. Zhao Y., Chaiswing L., Velez J.M., Batinic-Haberle I., Colburn N.H., Oberley T.D., St Clair D.K. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res. 2005, 65:3745-3750.
90. Zhitkovich A. Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem. Res. Toxicol. 2005, 18:3-11.
91. Zhitkovich A., Peterson-Roth E., Reynolds M. Killing of chromium-damaged cells by mismatch repair and its relevance to carcinogenesis. Cell Cycle 2005, 4:1050-1052.